Abstract
The incidence of stroke is gradually increasing in the industrialized world, and is a major cause of long-lasting disability. Several different strategies have been investigated as a means of either preventing the occurrence of stroke or suppressing the subsequent enlargement of the in-farct volume. However, due to the narrowness of the therapeutic time window, we are still far from achieving an effective response. One finding that has offered new hope is the discovery that neurogenesis, long regarded as an impossibility in the adult brain, does indeed occur. This raises the possibility that the damaged brain might in fact be able to recover as well as other tissues and organs. In this paper, we will review both existing and potential strategies for the treatment of cerebrovascular disease. In particular, we will focus on the prospects of pituitary adenylate cyclase-activating polypeptide (PACAP), a neuropeptide that has been shown to exert both neuroprotective and neurogenic effects.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe K, Yuki S, Kogure K (1993) Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19:480–485.
Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301–331
Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963–970
Banks WA, Kastin AJ, Komaki G, Arimura A (1993) Passage of pituitary adenylate cyclase activating polypeptidel-27 and pituitary adenylate cyclase activating polypeptidel-38 across the blood-brain barrier. J Pharmacol Exp Ther 267:690–696
Banks WA, Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S (1996) Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann N Y Acad Sci 805:270–279
Cazillis M, Gonzalez BJ, Billardon C, Lombet A, Fraichard A, Samarut J, Gres-sens P, Vaudry H, Rostene W (2004) VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Eur J Neurosci 19:798–808
De Keyser J, Uyttenboogaart M, Koch MW, Elting JW, Suiter G, Vroomen PC, Luijckx GJ (2005) Neuroprotection in acute ischemic stroke. Acta Neurol Belg 105:144–148
Dohi K, Mizushima H, Nakajo S, Ohtaki H, Matsunaga S, Aruga T, Shioda S (2002) Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways. Regul Pept 109:83–88
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4:1313–1317
Gage FH (2000) Mammalian neural stem cells. Science 287:1433–1438
Haapaniemi H, Hillbom M, Juvela S (1997) Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 28:26–30
Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295:547–553
Lichtenwalner RJ, Parent JM (2006) Adult neurogenesis and the ischemic forebrain. J Cereb Blood Flow Metab 26:1–20
Mercer A, Ronnholm H, Holmberg J, Lundh H, Heidrich J, Zachrisson O, Ossoinak A, Frisen J, Patrone C (2004) PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res 76:205–215
Ohno F, Watanabe J, Sekihara H, Hirabayashi T, Arata S, Kikuyama S, Shioda S, Nakaya K, Nakajo S (2005) Pituitary adenylate cyclase-activating polypeptide promotes differentiation of mouse neural stem cells into astrocytes. Regul Pept 126:115–122
Ohtaki H, Dohi K, Nakamachi T, Yofu S, Endo S, Kudo Y, Shioda S (2005) Evaluation of brain ischemia in mice. Acta Histochem Cytochem 38:99–106.
Ohtaki H, Nakamachi T, Dohi K, Aizawa Y, Takaki A, Hodoyama K, Yofu S, Hashimoto H, Shintani N, Baba A, Kopf M, Iwakura Y, Matsuda M, Arimura A, Shioda S (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with interleukin-6. Proc Natl Acad Sci USA (in press)
Reglodi D, Somogyvari-Vigh A, Vigh S, Kozicz T, Arimura A (2000) Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31:1411–1417
Reglodi D, Tamas A, Somogyvari-Vigh A, Szanto Z, Kertes E, Lenard L, Arimura A, Lengvari I (2002) Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23:2227–2234
Sakai Y, Hashimoto H, Shintani N, Katoh H, Negishi M, Kawaguchi C, Kasai A, Baba A (2004) PACAP activates Racl and synergizes with NGF to activate ERK1/2, thereby inducing neurite outgrowth in PC12 cells. Brain Res Mol Brain Res 123:18–26
Sievertzon M, Wirta V, Mercer A, Frisen J, Lundeberg J (2005) Epidermal growth factor (EGF) withdrawal masks gene expression differences in the study of pituitary adenylate cyclase-activating polypeptide (PACAP) activation of primary neural stem cell proliferation. BMC Neurosci 6:55
Song H, Stevens CF, Gage FH (2002) Astroglia induce neurogenesis from adult neural stem cells. Nature 417:39–44
Suzuki R, Arata S, Nakajo S, Ikenaka K, Kikuyama S, Shioda S (2003) Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Brain Res Mol Brain Res 115:10–20
Szabo K, Lanczik O, Hennerici MG. (2005) Vascular diagnosis and acute stroke: what, when and why not? Cerebrovasc Dis 20Suppl 2:11–8
Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330–338
Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S, Banks WA (1996) Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 736:280–286
Zhou CJ, Kikuyama S, Nakajo S, Hirabayashi T, Mizushima H, Shioda S (2000) Splice variants of PAC1 receptor during early neural development of rats. Peptides 21:1177–1183
Zhou CJ, Shioda S, Shibanuma M, Nakajo S, Funahashi H, Nakai Y, Arimura A, Kikuyama S (1999) Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage. Neuroscience 93:375–391
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this paper
Cite this paper
Ohtaki, H. et al. (2007). Does PACAP have therapeutic potential in the field of neuroregenerative medicine?. In: Kusano, M., Shioda, S. (eds) New Frontiers in Regenerative Medicine. Springer, Tokyo. https://doi.org/10.1007/978-4-431-38208-9_16
Download citation
DOI: https://doi.org/10.1007/978-4-431-38208-9_16
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-38207-2
Online ISBN: 978-4-431-38208-9
eBook Packages: MedicineMedicine (R0)